STAT+: Wyden says Merck and Abbott aren’t cooperating with probe into pharma tax practices
In his ongoing quest to probe pharmaceutical industry tax practices, the head of the U.S….
Author: STAT
Can we really get better Covid vaccines? There are big hurdles, but some hope
On Tuesday, White House officials gathered scientists, pharmaceutical executives, and experts in public health at…
.jpg)
STAT+: Pharmalittle: Teva reaches $4.25 billion deal over its role in opioid crisis; feds probe Cassava over Alzheimer’s drug data
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot…
Opinion: The future of health care is here. When will it be everywhere?
To paraphrase Canadian-American speculative fiction writer William Gibson: The future of health care is already…
STAT+: Genomics is racing toward a $100 genome. Are we ready for it?
As the cost of DNA sequencing plummets, we’re fast approaching a point when decoding a…
Opinion: The Morris ALS Principles: A model for empowering all disease communities
The FDA’s decision to delay its highly anticipated review of AMX0035, a new drug for…
Drawing on therapy developed to save soldiers, an app aims to prevent suicide in those at highest risk
It’s a problem so complex, so fraught with stigma and treatment complications, that innovation has…
Drugmaker Teva latest to settle opioid lawsuits nationally
Drugmaker Teva announced Tuesday that it has agreed to contribute more than $4.3 billion in…
White House summit sets lofty goals for new Covid vaccines — but largely sidesteps questions of funding
WASHINGTON — Top White House officials spent Tuesday laying out a vision for a Covid…
‘Critically important work’: Adm. Rachel Levine on efforts to combat gender-based discrimination in health care
A day after the Department of Health and Human Services announced plans to strengthen protections…
STAT+: FDA’s decision to review a Biogen ALS drug is met with skepticism and uncertainty on Wall Street
Once again, the U.S. Food and Drug Administration made a surprise move regarding an experimental…
Opinion: Value-based payment has produced little value. It needs a time-out
The value-based payment crusade is now two decades old. But despite the tens of billions…
Are we primed for Amazon’s primary care?
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
What to know about polio, a disease once again vying for attention
Depending on how young you are, your mother may remember polio. Your grandmother, though, would…
STATUS List Spotlight: Blazing a Trail for Transgender Rights ft. Admiral Rachel L. Levine
Editor’s note: A livestream of the conversation will be embedded below at 2:00 pm. This February,…
STAT+: Pharmalittle: FDA will review Biogen ALS drug despite inconclusive results; Shkreli launches drug-discovery software company
Rise and shine. Another busy day is on the way. Indeed, the official to-do list…
STAT+: FDA agrees to review ALS treatment from Biogen, despite inconclusive clinical trial results
The Food and Drug Administration has agreed to review a treatment for a rare, genetically…
Opinion: Clinician-administrator relationships are ‘on life support.’ Here’s how to heal them
Much has been written about the decades-long erosion of the once-solid relationship between patients and…
Senators demand answers about federal prisons’ scant use of Covid therapeutics
WASHINGTON — Fourteen senators are demanding that the federal Bureau of Prisons explain its scant…
Opinion: The FDA needs to get ready to evaluate synthetic cells, the next generation of therapeutics
Expanding new medical treatments requires pushing — and sometimes breaking — the boundaries of what…
STAT+: ‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing
WASHINGTON — The pharmaceutical industry, notorious for its deep pockets and aggressive lobbying tactics, has a…
STAT+: American Cancer Society’s VC arm partners with Third Rock on oncology companies
Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention…
STAT+: Despite their anger over high drug prices, Americans are giving pharma credit for helping contain Covid-19
WASHINGTON – Nearly three quarters of Americans give the pharmaceutical industry credit for helping contain…
STAT+: ‘No magic bullet’: For drugmakers and the FDA, clinical trials on ultra-rare diseases pose thorny challenges
Walker Burger is beside himself with worry. The 33-year-old relies on an experimental medicine to…
Encouraged by right-wing doctor groups, desperate patients turn to ivermectin for long Covid
Almost two years have passed since Dean Fritzemeier fell ill with Covid in October 2020….
STAT+: McDonald’s is criticized for leaving antibiotic reduction targets off its menu
Several advocacy groups have a beef with McDonald’s over its policy for using antibiotics in…
STAT+: Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs
In another setback for the pharmaceutical industry, a federal appeals court panel upheld a ruling…
New studies offer theory on cause of unusual hepatitis cases in kids
There is a new theory about what may be causing puzzling cases of pediatric hepatitis…
Patients’ new credit card crunch, Amazon’s getting serious, and inflation has entered the chat
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Pharmalittle: White House to launch effort for new generation of Covid shots; Indian court rejects bail pleas in Biocon bribery case
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements
In the 1990s, state Attorneys General learned how to leverage their resources when they retained…
Collateral damage of the Fed’s interest rate hikes: People who put medical bills on credit cards
Tiffany Yarina didn’t max out her credit card from a home renovation or luxury purchase….
White House to launch effort to develop next generation of Covid vaccines
The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19…
Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals
Psychedelic medicine is having a moment of tremendous growth and innovation as researchers rediscover its…
STAT+: A troubling report on Cerner’s VA rollout offers a rare look into the hidden harms of health records
The rollout of Cerner’s electronic health record in Veterans Affairs hospitals has been a high-profile…
.jpg)
STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
The term “brain-computer interface,” or BCI, has been buzzing around Silicon Valley and the mainstream…
Two deadly days in St. Louis: An overdose cluster kills 8 Black people — and shows the new shape of the addiction crisis
ST. LOUIS — The calls for help poured in throughout the day: Overdose after overdose…
Opinion: Poorer nations need assurances of dedicated vaccine supplies before the next pandemic
Anyone wondering whether Covid-19 vaccines are making a difference to this deadly and persistent pandemic…
Opinion: Deal between Amazon and One Medical deal has massive implications for the future of primary care
Amazon’s announcement this week that it would acquire One Medical, a primary care provider, for…
WHO declares monkeypox outbreak a public health emergency
The World Health Organization on Saturday declared the unprecedented monkeypox outbreak that has spread around…
Acne bacteria, study suggests, thrive when skin oil turns infection-fighting cells into accomplices
Cutibacterium acnes, a crunchy Cheeto-shaped bug that lives on human skin, loves the oily pocket…
STAT+: Amazon has big ambitions in primary care. One Medical is just the latest piece of its plan
When it comes to primary care, One Medical is hardly Amazon’s first rodeo. By the…
Opinion: Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation
Democrats have sent the legislative text of a sweeping proposal for drug price controls to…
STAT+: Pharmalittle: Congress may miss deadline to pass FDA user-fee bill; ViiV is urged to lower price for its HIV prevention drug
And so, another working week will soon draw to a close. Not a moment too…
Opinion: There’s no ‘Moonshot’ or ‘Warp Speed’ for rare diseases. There should be
The term “rare disease” is both an apt descriptor and a misnomer. Individually, each rare…
Opinion: New price transparency regulations for hospitals, insurers empower patients
Many Americans are accustomed to shopping around for the best deal. We can access reams…
‘There’s no one long Covid’: Experts struggle to make sense of the continuing mystery
Robert Gallo apologized for still coughing. The day before President Biden tested positive for Covid-19,…
As new variant spreads, a crucial drug to protect the most vulnerable goes vastly underused
Jennifer Padgett has spent 2 1/2 years terrified for her immunocompromised daughter, Hannah. Hannah catches…
STAT+: 5 burning questions about Amazon’s $3.9 billion acquisition of One Medical
With its acquisition of One Medical, Amazon is setting its sights squarely on shaking up…
After STAT report, GOP lawmakers seek answers about defunct NIH oversight committee
WASHINGTON — A trio of congressional Republicans wants to know why a committee tasked with…